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Abstract
Background: Chlamydia is the most common curable sexually transmitted infection (STI) in the Netherlands. The
majority of chlamydia diagnoses are made by general practitioners (GPs). Baseline data from primary care will
facilitate the future evaluation of the ongoing large population-based screening in the Netherlands. The aim of this
study was to assess the usefulness of electronic medical records for monitoring the incidence of chlamydia cases
diagnosed in primary care in the Netherlands.
Methods: In the electronic records of two regional and two national networks, we identified chlamydia diagnoses
by means of ICPC codes (International Classification of Primary Care), laboratory results in free text and the
prescription of antibiotics. The year of study was 2007 for the two regional networks and one national network, for
the other national network the year of study was 2005. We calculated the incidence of diagnosed chlamydia cases
per sex, age group and degree of urbanization.
Results: A large diversity was observed in the way chlamydia episodes were coded in the four different GP
networks and how easily information concerning chlamydia diagnoses could be extracted. The overall incidence
ranged from 103.2/100,000 to 590.2/100,000. Differences were partly related to differences between patient
populations. Nevertheless, we observed similar trends in the incidence of chlamydia diagnoses in all networks and
findings were in line with earlier reports.
Conclusions: Electronic patient records, originally intended for individual patient care in general practice, can be
an additional source of data for monitoring chlamydia incidence in primary care and can be of use in assessing
the future impact of population-based chlamydia screening programs. To increase the usefulness of data we
recommend more efforts to standardize registration by (specific) ICPC code and laboratory results across the
existing GP networks.
Background
Genital Chlamydia trachomatis infection is the most
common curable sexually transmitted infection (STI) in
the Netherlands [1]. In men, the most common clinical
manifestation of a chlamydia infection is urethritis. In
women, it can cause cervicitis and serious complications
including upper genital tract infections and it is consid-
ered one of the main causes of pelvic inflammatory
disease (PID) [2]. Infections are asymptomatic in more
than 50% of infected men and 70% of infected women
[2]. Since PID and tubal infertility have a large impact
on women’s reproductive health and treatment is costly,
screening programmes have been introduced to control
chlamydia through early detection and treatment of
asymptomatic infections [3]. Moreover, screening and
timely treatment may reduce transmission in the
population.
In England, the General Practice Research Database
(GPRD) has been used to study incidence of chlamydia
diagnoses in primary care [4,5]. In the context of the
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ing Programme (NSCP), the GRPD proved to be an
important source of valuable baseline data. In the Neth-
erlands, the decision to implement population-based
screening on a national level is still pending. After a
pilot study that assessed the feasibility of screening and
the prevalence of chlamydia [6], a large scale Chlamydia
Screening Implementation (CSI) project targeting both
men and women started in three regions in the Nether-
lands in 2008 [7,8]. The patient population visiting gen-
eral practitioners (GPs) and testing positive for
chlamydia infection is expected to change in regions
where screening is implemented with a substantial cov-
erage. We want to be able to monitor any changes of
the incidence of chlamydia diagnoses in primary care. In
addition, baseline information of the incidence of chla-
mydia cases, diagnosed in primary care will be needed
to parameterize mathematical models to study the popu-
lation impact of chlamydia screening programmes [9].
In the Netherlands, the national surveillance of chla-
mydia is mainly based on data from STI centres,
reported to the National Institute of Public Health and
the Environment [10]. Dutch STI-centres provide free
and anonymous STI testing and care to high-risk
groups: persons that fit certain criteria (young age, men
who have sex with men, ethnic origin from HIV-ende-
mic areas, and STI-related symptoms). Although surveil-
lance of high-risk groups is important for STIs, the
majority of genital chlamydia infections is seen by GPs
[7,11,12]. In the Netherlands all inhabitants are regis-
tered with a GP; the GP acts as a gatekeeper for second-
ary care. Reports on the incidence rates of chlamydia
diagnoses in primary care are limited. A recent study
comparing data from the STI-centre surveillance and
electronic medical records of a nationwide sentinel GP
network concluded that GPs accounted for 80-85% of
STI-diagnoses [13]. The chlamydia reporting rate, based
on these two data sources was 220/100,000 population
or 36,000 cases reported per year. However, uncertain-
ties remained on the case definition of chlamydia in the
GP electronic records.
To obtain more insight into occurrence and reporting
of chlamydia diagnoses in GP practice, we compared the
incidence of chlamydia diagnoses in the GP network
studied in ref 13 with another nationwide and two
regional networks. We described the variation in the
recording of chlamydia infections and we discussed pos-
sible explanations for this variations and the usefulness
of these data for the purpose of monitoring chlamydia
incidence in the population. This study, together with
data form STI-centres, served as baseline information
on incidence of chlamydia diagnoses in primary care for
the evaluation of the CSI project.
Methods
GP networks
For research and education purposes, departments of
family medicine of most Dutch universities have primary
care networks consisting of GPs from different practices
in the region. There are 11 GP networks in the Nether-
lands which do not overlap. The networks are indepen-
dent, there is no routine dataflow to a national database.
These GP networks collect computer based information
about patient care using uniform data collection and
registration methods. At regular intervals the information
from local registration systems is fed into a central data-
base. On the national level, two GP networks exist that
collect data on morbidity, prescriptions and referrals.
The aim of regional and national networks is to collect
data about primary care in a standardized way, suitable
for scientific evaluation. For our study we extracted infor-
mation about chlamydia diagnoses and treatment from
four electronic networks. We selected two nationwide
networks as to be able to compare earlier findings in [13]
with results form another national network. Since the
CSI project was conducted in Amsterdam, Rotterdam
and the southern part of Limburg we selected also the
two GP networks in Amsterdam. In Rotterdam there was
not a regional GP network available; the database of the
GP network in Limburg has a focus on a limited number
of diagnoses, largely chronic diseases. Therefore, only
two regional networks from Amsterdam were included.
Ethical approval for this study was not necessary since all
patient information in the databases is anonymous, no
intervention was done and all patients were informed
that their GP participates in scientific research. The four
networks: Amsterdam Medical Centre (AMC) network,
Academic General Practice Network VU University med-
ical centre (VUmc), Integrated Primary Care Information
(IPCI) network and Landelijk Informatie Netwerk Hui-
sartsen (LINH, Netherlands Information Network of
General Practice) provided approval for the use of the
GP data for this specific study.
Definition of Chlamydia trachomatis diagnoses using ICPC
codes
To define chlamydia diagnoses in GP networks, we used
a selection of codes within the International Classifica-
tion of Primary Care (ICPC-1), a worldwide system for
coding patient symptoms and diagnoses in primary care
[14]. Depending on clinical features chlamydia infections
in men and women are recorded under general main-
c o d e st h a ti n c l u d eab r o a d e rr a n g eo fd i a g n o s e s( f o r
vaginitis, cervicitis, PID and epididymitis) or specific
sub-codes (diagnoses with chlamydia). Since some GPs
only register main-codes (ending with .00) and no sub-
codes, these main-codes were included only if the
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date) fitted a chlamydia diagnosis. The following anti-
biotics were included: Azythromycin, Doxycyclin, Amox-
icillin, Erythromycin, Ciprofloxacin, and Ofloxacin; they
were coded using the Anatomical Therapeutic Chemical
(ATC) classification scheme applied by the WHO. We
did not use doses of antibiotics.
Electronic networks and data extraction
Amsterdam Medical Centre (AMC) network
Five primary healthcare centres in the south-east of
Amsterdam participate in the continuous morbidity
registration network of the Department of General Prac-
tice, AMC, University of Amsterdam. For our study, we
selected all patient records in the year 2007 with a chla-
mydia-related ICPC code or with the string ‘chlam’ in
the free text. We verified these probable chlamydia diag-
noses, based on information of laboratory results in the
free text and the prescription of chlamydia-specific anti-
biotics. Patients’ sex, age, date of consultation and dura-
tion of registration were used as well as the total
number of patients and their time registered in the par-
ticipating practices in 2007 (patient years).
Academic General Practice Network VU University medical
center (VUmc)
The VUmc general practitioner network covers 21 prac-
tices in the cities Haarlem (13), Amstelveen (1) and
Amsterdam (7). Similar to the data extraction of the
AMC database, a researcher examined all medical
records of 2007 containing the string ‘chlam’ or a
related ICPC code to determine chlamydia episodes.
T h es a m ep a t i e n t s ’ characteristics as in the AMC net-
work were available with exception of the time period
that patients had been registered in practice.
Integrated Primary Care Information (IPCI) network
The IPCI database is a longitudinal observational database
which contains data from electronic medical records of 81
practices throughout the Netherlands. Medical records of
2007 were not available; therefore we used all medical
records of 2005 to identify chlamydia cases. Like in the net-
works stated above, records were searched for the string
‘chlam’ or specific ICPC codes. The identified records were
manually validated using all information available in the
database to determine the presence of a chlamydia diagno-
sis. The IPCI database contains demographic information
of the patient (date of birth, sex, degree of urbanization of
home address, duration of registration), medical notes per
consultation (ICPC codes, symptoms, physical examina-
tion, assessments and diagnoses), prescriptions, referrals,
hospitalizations and laboratory results.
Landelijk Informatie Netwerk Huisartsen (LINH) network
LINH is based on electronic medical records from 81 gen-
eral practices, spread throughout the Netherlands. Data
include longitudinal information on patient’s characteristics
such as age, sex, degree of urbanization of home address,
duration of registration in practice, as well as medical infor-
mation on consultations, prescriptions, referrals, and diag-
noses. Based on ICPC codes and ATC codes probable
chlamydia infections in 2007 were identified (similar to pre-
vious study) [13]. More than in the three other networks,
GPs participating in the LINH network are instructed to
use ICPC codes for every patient contact. Free text from
medical records is not available in this database.
Data analysis
Chlamydia infections were counted as ‘episodes’:o n eo r
more patient consultations for the same medical diagno-
sis. In all four networks we included a second episode
for the same patient only after an interval of at least two
months after the first diagnosis. We assessed diagnoses
by ICPC codes, free text and ATC codes in the different
networks and calculated incidence of chlamydia diag-
noses per age group. The incidence of chlamydia diag-
noses was defined as the number of new chlamydia
episodes divided by the number of patient years in parti-
cipating practices in the AMC, IPCI and LINH database.
For the denominators of the VUmc network we used
the numbers of patients at the end of the year. We also
described the incidence of diagnosed cases by level of
population density in the LINH and IPCI network.
In accordance with Statistics Netherlands the follow-
ing definitions for population density were used:
￿ Level 1: highly urban: 2,500 addresses or more per
square km
￿ Level 2: 1,500 to 2,500 addresses per square km
￿ Level 3: 1,000 to 1,500 addresses per square km
￿ Level 4: 500 to 1,000 addresses per square km
￿ Level 5: rural: fewer than 500 addresses per square
km
Results
Characteristics of patient populations in the four
networks
Table 1 shows a number of characteristics of the study
population of the selected networks and the way chla-
mydia was defined. The size of study population in the
different networks varied from 35,137 to 327,725
depending on the number of practices included. In all
networks slightly more women than men were regis-
tered. The patients in the catchment area of the AMC
network had a lower socioeconomic status and were
more often of non-western origin than in the other net-
works. The AMC and VUmc network both covered a
highly urbanized population, whereas the two national
networks contain practices from areas with a population
density representative for the whole country.
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The use of ICPC codes in the identified (probable) chla-
mydia episodes in the electronic records varied largely
among the four networks (table 2) for both men and
women. The proportion of episodes identified with any
ICPC code differed. More than 40% of the chlamydia
diagnoses in the AMC and IPCI network did not have
an ICPC code, while in the VUmc network more than
90% and in the LINH network all records contained a
code. The availability of ICPC codes facilitated the
search for chlamydia diagnoses in VUmc and LINH net-
works. Second, there were differences in the use of the
various ICPC codes in the GP networks. In the VUmc
and LINH network the code for PID (X74 and X74.01)
was found more frequently than in the AMC and IPCI
network. In all networks except the VUmc network
code X84.00 was sometimes used, while this is not an
appropriate code to define a chlamydia diagnosis. Unlike
t h eA M Ca n dL I N Hn e t w o r k s ,ac o n s i d e r a b l ep a r to f
the probable chlamydia cases in the VUmc and IPCI
network were registered under the code X99.00 (other
genital disease in women). In the LINH network, the
main-codes (X74.00, X84.00, and Y99.00) and sub-code
Y74.02 (epididymitis) were seen more frequently than in
the other networks. Finally, the proportion of episodes
defined by sub-codes specific for chlamydia varied lar-
gely, this was 40.6% of chlamydia cases in the IPCI-net-
work 48.2% of chlamydia diagnoses at AMC practices,
68% in the LINH-network and 74.5% in the VUmc-
network.
Incidence of chlamydia diagnoses in the GP networks
The estimated incidence of chlamydia diagnoses was
higher in the regional networks around Amsterdam
than in the nationwide networks. The incidence rate
was 590.2/100,000 for AMC, and 275.4/100,000 for
VUmc compared to 103.2/100,000 for IPCI and 195.9/
100,000 for LINH network (table 1). The incidence rates
were lower in men than in women and peaked in differ-
ent age groups (see Figure 1a and 1b). In the LINH and
VUmc networks incidence rates were highest for men in
the age group 20-24 years old (461 and 1060 per
100,000 respectively) while in the AMC and IPCI net-
work men from 25 to 29 years had the highest incidence
of chlamydia diagnoses (1012 and 423 per 100,000
respectively). With increasing age numbers of chlamydia
diagnoses declined in all the networks. In the LINH net-
work, men aged 50 years and older had a relatively
higher incidence rate than in the other networks. High-
est rates in women were seen in the AMC network and
especially in the youngest age group of 15 to 19 years
old (2466 per 100,000). The VUmc, LINH and IPCI net-
work had the highest incidence in the age group 20 to
24 years old (936, 702 and 906 per 100,000 respectively).
Incidence of chlamydia diagnoses related to population
density
For the nationwide networks IPCI and LINH, we further
stratified the incidence rates by degree of urbanization
(table 3). The highest rates were seen in the highly urba-
nized areas in men and women at the age of 15 to 29.
Table 1 Overview of general practice networks
AMC network VUmc network IPCI LINH
Region South-east Amsterdam Amsterdam, Haarlem,
Amstelveen
Nationwide Nationwide
Year of data
extraction
2007 2007 2005 2007
No of
practices
52 1 8 1 8 1
Size of
network
population
35,137 66,402 235,307 327,725
Percentage of
women
53% 53% 51% 51%
Patient
characteristics
Lower socioeconomic status and more
often non-western descent than the
general population; living in an highly
urbanized area
More often of Dutch
descent; living in an
highly urbanized area
Representative
sample of the
general population
[21]
Representative sample of the general
population [22]
Definition of
chlamydia
A chlamydia diagnosis was based on
laboratory results, appropriate antibiotics or
correct ICPC code in the medical record
Idem, based on
laboratory results,
antibiotics and ICPC
code
Idem, based on
laboratory results,
antibiotics and ICPC
code
A chlamydia diagnosis was based on a
specific ICPC sub-code or main-code
combined with a chlamydia-related
antibiotic
Overall
incidence rate
per 100,000
(95% CI)
590.2 (506.7 - 687.3) 275.4 (233.6 - 324.7) 103.2 (89.2 - 118.7) 195.9 (179.3 - 214.1)
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higher than in semi-rural areas. The overall incidence of
chlamydia diagnoses in the youngest age groups was
similar in both networks: in men 297 and 325 per
100,000, in women 535 and 525 in IPCI and LINH net-
work respectively.
Discussion
Our study showed that electronic databases from pri-
mary care networks can be used to estimate the inci-
dence of chlamydia diagnoses. However, we observed
variability in the incidence rate reported by the four net-
works; different registration rules/habits and socio-
demographic characteristics of the patient populations
in the networks contributed to this variability. Diag-
nosed cases of chlamydia infection were recorded in sev-
eral ways in GP electronic records. While most GPs
used ICPC codes for recording details of their diagnosis,
others resorted to free text fields from which extracting
standardized diagnoses is difficult and time-consuming.
The application of ICPC codes in general as well as the
use of specific (sub)codes differed from network to net-
work hampering comparability and the analysis of over-
all trends.
The estimated incidence of chlamydia diagnoses varied
from 103 to 590 per 100,000 in the four networks. Despite
the large difference in incidence rates, similar trends were
observed. Chlamydia incidence was highest in the young-
est age groups (15 to 30 years), where incidence rates in
women were approximately twice as high as in men. This
is in agreement with what is found in Dutch STI clinics,
where the numbers of young women diagnosed with chla-
mydia are higher than in young men [1]. The highest inci-
dence rates of diagnosed cases were found in the AMC
network. Patients included in the AMC network, in the
south-eastern part of Amsterdam have on average a lower
socioeconomic status and are more often of non-western
origin. Based on a classification of Statistics Netherlands
Table 2 Use of ICPC code in different GP networks for patients identified in our study as having a chlamydia
diagnosis
Reported
ICPC
codes
Explanation code AMC 2007% (N = 164,
49 men; 115 women)
VUmc 2007%
(N = 141, 55 men;
86 women)
IPCI 2005% (N = 189,
80 men; 109 women)
LINH 2007% (N = 485,
229 men; 256 women)
No code Verified in free text and in
laboratory results
43 7.1 42.9 0
X74.00 PID 2.4 2.1 2.6 10.5
X74.04
X74.01 PID by chlamydia - 8.5 - 2.7
X74.05 Other pelvic infection - - 2.1 -
X84.00 Vaginitis 1.8 - 2.1 10.5
X84.01 Vaginitis by chlamydia 17.7 10.6 - 12.2
X85.00 Cervicitis 0.6 - 5.3 3.3
X85.01* Cervicitis by chlamydia 15.9 19.9 5.3 13
X85.04 Other cervical disease - - 0.5 -
X99.00 Genital disease or sexually
transmitted infection in
women
1.2 16.3 14.8 -
X99.03
X99.05
Y74.00 Orchitis/Epididymitis 0.6 - 1.1 16.7
Y74.01
Y74.02
Y99.00 Genital disease or sexually
transmitted infection in men
1.8 - 23.3 7.8
Y99.01
Y99.05
Y99.06
Y99.03 Genital disease by chlamydia
in men
14 35.5 - 22.9
Y99.07 Unknown code - - - 0.4
Total 100 100 100 100
*In the IPCI network: cervicitis.
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all patients in these practices belonged to the lowest of
five socioeconomic status levels while 53% were of non-
western descent, in 2007. Other studies revealed that the
risk of acquiring chlamydia is associated with ethnicity
and social economic status [6,15]. In addition, the south-
east of Amsterdam is a highly urbanized area and as in the
IPCI and LINH network we observed a general increase in
chlamydia incidences with higher degree of urbanization.
In contrast, the relatively high incidence in rural areas in
Figure 1 Incidence of chlamydia diagnoses per 100,000 person-years in men (A) and women (B) in primary care networks.( *i nt h e
VUmc network, total number of patients)
Table 3 Incidence of chlamydia diagnoses per 100,000 person-years in IPCI and LINH network concerning degree of
urbanization
Degree of urbanization Men all ages Women all ages men 15-29 women 15-29
IPCI LINH IPCI LINH IPCI LINH IPCI LINH
Level 1: highly urban 132.5 340.8 156.2 371.7 427.4 634.1 650.3 881.1
95%CI 93-184 277-419 112-212 307-450 276-635 471-853 453-906 703-1105
Level 2 96.6 197.7 144.4 248.5 341.5 364.2 616.1 682.1
95%CI 61-146 141-278 99-203 185-333 196-558 217-611 405-901 472.-984
Level 3 54.9 181.2 67.8 166.3 140.7 255.4 330.8 331.9
95%CI 33-87 130-253 43-103 118-235 63-276 243-622 197-524 201-547
Level 4 52.1 138.9 146.7 97.1 201.8 210.3 686.8 261.5
95%CI 22-107 103-187 89-230 68-139 68-480 125.-353 385-1141 163-418
Level 5: rural 75.6 108.3 101.8 173.6 282.3 83.1 498.1 441.0
95%CI 21-202 73-161 34-242 126-239 56-905 32-214 138-1329 286-680
Overall 87.3 189.7 119.1 207.9 296.3 325.3 535.9 525.1
95%CI 70-108 167-216 98.-143 184-235 225-389 265-399 435-660 450-613
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not be excluded that this reflects a chance effect due to
low numbers, further investigations into testing practices
are needed to explore this finding.
Our results regarding the trends in incidence of chla-
mydia diagnoses by age, sex and degree of urbanization
compare well with a large population-based chlamydia
screening pilot study conducted in 2002/2003. In that
s t u d y ,t h ep r e v a l e n c eo fc h l a m y d i aw a sf o u n dt ob e2 %
among 15-29 years old participants (1.5% in men and
2.5% in women). Prevalence was lower in rural areas
(0.6%) compared to very highly urbanized areas (3.2%)
[6]. Assuming an (untreated) chlamydia infection lasts
on average one year, these prevalence rates can be
roughly interpreted as annual incidence rates [16-18],
which would mean an incidence rate of 1500 and 2500
per 100,000 in young men and women. Our findings in
the nationwide networks (an incidence of 300 and 500
per 100,000 in young men and women) indicate that
about 20% of the total incident chlamydia cases in that
age group is diagnosed by GPs.
Because chlamydia was not recorded under one code
and reporting laboratory results was not standard,
uncertainty remains about whether all of the extracted
cases were actually chlamydia cases and about how
many cases of chlamydia were recorded in a way that
they were not identified by our extraction rules. The
definition of a chlamydia infection that uses fixed main-
codes in combination with the code for a specific anti-
biotic treatment in the LINH network could potentially
lead to an overestimation of chlamydia incidence espe-
cially in higher age groups. For example, the antibiotic
treatment for epididymitis in older men is also pre-
scribed for other pathogens than Chlamydia trachoma-
tis. Information about chlamydia testing results were
lacking for the majority of patients in these networks.
Finally, the years of study were not the same for every
network, which could have influenced the observed inci-
dence rates.
A study of morbidity rates in general practice registra-
tion networks in the Netherlands identified potential
reasons for the observed variability that apply to our
findings as well [19]. We also perceived differences in
the methodological characteristics of the networks, such
as definitions and registration rules used. Another rea-
son for variability pertains to the variety of testing prac-
tices used among GPs. A qualitative study exploring the
reasons for variation in diagnostic testing found major
differences between high and low chlamydia testers [20].
Possibly the rate of testing is higher in an urban setting
compared to a rural area, explaining at least partly the
difference in incidence rates in both areas. The last rea-
son these authors mentioned was related to the socio-
demographic characteristics of the catchment population
of the networks, which is certainly true for the differ-
ences between the national and regional networks in
our study, as described above.
Conclusion
In this study, we have demonstrated that electronic
medical records, originally intended for individual
patient care in general practice, can be an additional
source of information about incidence of chlamydia as
diagnosed in primary care. These estimates would be
helpful to assess the future impact of population-based
chlamydia screening programs. In view of the consider-
able variation in the way chlamydia has been coded and
reported, we recommend that more efforts should be
undertaken to standardize registration rules and record-
taking for GP networks. In meetings of representatives
of the GP networks, methods of registration could be
discussed and standardized. The implementation of a
single ICPC code for chlamydia infections, as it is
defined in ICPC-2 classification, preferably combined
with recording of laboratory results in all GP practices
that are connected to a data-collecting network is neces-
sary to achieve better comparability of GP registries.
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